Western Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Sell |
2,692
-234
| -8% | -$94.9K | 0.06% | 253 |
|
|
2025
Q1 | $1.46M | Buy |
2,926
+173
| +6% | +$86.1K | 0.1% | 198 |
|
|
2024
Q4 | $1.43M | Sell |
2,753
-1,890
| -41% | -$983K | 0.09% | 189 |
|
|
2024
Q3 | $2.87M | Buy |
4,643
+693
| +18% | +$429K | 0.16% | 125 |
|
|
2024
Q2 | $2.18M | Buy |
3,950
+62
| +2% | +$34.3K | 0.16% | 126 |
|
|
2024
Q1 | $2.26M | Sell |
3,888
-953
| -20% | -$554K | 0.18% | 119 |
|
|
2023
Q4 | $2.57M | Sell |
4,841
-169
| -3% | -$89.7K | 0.19% | 115 |
|
|
2023
Q3 | $2.54M | Buy |
5,010
+123
| +3% | +$62.3K | 0.21% | 100 |
|
|
2023
Q2 | $2.55M | Sell |
4,887
-92
| -2% | -$48K | 0.22% | 100 |
|
|
2023
Q1 | $2.87M | Buy |
4,979
+26
| +0.5% | +$15K | 0.27% | 85 |
|
|
2022
Q4 | $2.73M | Sell |
4,953
-3,005
| -38% | -$1.65M | 0.28% | 92 |
|
|
2022
Q3 | $4.06M | Buy |
7,958
+2,473
| +45% | +$1.26M | 0.23% | 96 |
|
|
2022
Q2 | $2.99M | Buy |
5,485
+214
| +4% | +$117K | 0.17% | 135 |
|
|
2022
Q1 | $3.11M | Buy |
5,271
+2,829
| +116% | +$1.67M | 0.15% | 145 |
|
|
2021
Q4 | $1.62M | Buy |
+2,442
| New | +$1.62M | 0.16% | 139 |
|
|
2021
Q2 | $1.25M | Buy |
2,473
+400
| +19% | +$202K | 0.13% | 171 |
|
|
2021
Q1 | $946K | Buy |
2,073
+130
| +7% | +$59.3K | 0.13% | 172 |
|
|
2020
Q4 | $905K | Buy |
1,943
+437
| +29% | +$204K | 0.13% | 172 |
|
|
2020
Q3 | $665K | Buy |
+1,506
| New | +$665K | 0.11% | 194 |
|